A message from Robert McMaster, Vice Dean, Research.
I am pleased to announce that Dr. Hugh Kim has been appointed Director, Centre for Blood Research (CBR) for a five-year term, effective to December 31, 2029.
Dr. Kim is an associate professor in the Department of Oral Biological & Medical Sciences at the UBC Faculty of Dentistry, an associate member in the Department of Biochemistry & Molecular Biology and a principal investigator with the CBR.
A clinician-scientist, Dr. Kim’s research focuses on fundamental platelet physiology, and has been continuously funded by the Canadian Institutes of Health Research (CIHR) and Michael Smith Health Research BC. Dr. Kim is also an active leader in various national and international research initiatives and is committed to advancing the scientific understanding of blood disorders and improving treatment strategies through translational research.
As Director of the CBR, Dr. Kim will play a key role in shaping the centre’s strategic direction. His vision includes fostering a collaborative and inclusive environment, driving cutting-edge research and promoting interdisciplinary partnerships to further the CBR’s mission to transform the lives of patients with blood-related diseases. Dr. Kim is dedicated to supporting the next generation of researchers and creating more opportunities for mentorship and training within the centre.
Dr. Kim succeeds Dr. Ed Conway, whose exceptional leadership from 2009–2020 and again from 2023–2024 has positioned the CBR as a global leader in blood research. Under Dr. Conway’s guidance, the CBR made significant strides in both basic and clinical research. I extend my heartfelt gratitude to Dr. Conway for his dedication, leadership and outstanding contributions.
Please join me in thanking Dr. Conway, and congratulating Dr. Kim on his appointment.
